Growing community of inventors

Mechelen, Belgium

Piet Tom Bert Paul Wigerinck

Average Co-Inventor Count = 4.15

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Piet Tom Bert Paul WigerinckChristophe Peixoto (2 patents)Piet Tom Bert Paul WigerinckNicolas Triballeau (2 patents)Piet Tom Bert Paul WigerinckFlorence Sylvie Namour (2 patents)Piet Tom Bert Paul WigerinckJean-Michel Lefrançois (2 patents)Piet Tom Bert Paul WigerinckCatherine Jagerschmidt (2 patents)Piet Tom Bert Paul WigerinckRoland Blanqué (2 patents)Piet Tom Bert Paul WigerinckPierre Deprez (2 patents)Piet Tom Bert Paul WigerinckFrançois Nique (2 patents)Piet Tom Bert Paul WigerinckGerben Albert Eleutherius Van 't Klooster (1 patent)Piet Tom Bert Paul WigerinckGerben Albert Eleutherius Van 'T Klooster (0 patent)Piet Tom Bert Paul WigerinckPiet Tom Bert Paul Wigerinck (3 patents)Christophe PeixotoChristophe Peixoto (19 patents)Nicolas TriballeauNicolas Triballeau (3 patents)Florence Sylvie NamourFlorence Sylvie Namour (3 patents)Jean-Michel LefrançoisJean-Michel Lefrançois (3 patents)Catherine JagerschmidtCatherine Jagerschmidt (3 patents)Roland BlanquéRoland Blanqué (2 patents)Pierre DeprezPierre Deprez (2 patents)François NiqueFrançois Nique (2 patents)Gerben Albert Eleutherius Van 't KloosterGerben Albert Eleutherius Van 't Klooster (2 patents)Gerben Albert Eleutherius Van 'T KloosterGerben Albert Eleutherius Van 'T Klooster (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Galapagos Nv (2 from 116 patents)

2. Dart Therapeutics LLC (1 from 1 patent)


3 patents:

1. 10376520 - Methods for the treatment of cardiovascular disorders

2. 8383608 - Imidazolidine compounds as androgen receptor modulators

3. 7968581 - Imidazolidine compounds as androgen receptor modulators

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/8/2026
Loading…